In aplastic anemia progenitor cells have a reduced sensitivity to the effects of growth factors
- 1 September 1999
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 63 (3) , 141-148
Abstract
Abstract: We have recently shown that in patients with aplastic anemia (AA) recovering following immunosuppressive therapy, the persistent reduction in the bone marrow clonogenic potential is unrelated to suppressive effects of the myeloid stroma and intrinsic to the hematopoietic progenitors. We examined the mechanisms of this defect by determining the response of the aplastic CD34+ clonogenic precursors to proliferative signals induced by hematopoietic growth factors and comparing their results with those of a control population. Light density bone marrow mononuclear cells were lymphocyte and monocyte depleted and enhanced for the CD34+ progenitors by immunomagnetic selection. Selected progenitors were then cultured in the mixed colony assay with incremental concentrations of combinations containing erythropoietin (Epo), granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), interleukin‐3 (IL‐3) and c‐kit ligand. Bone marrow from aplastic patients had significantly fewer light density cells displaying the CD34 antigen (mean 0.65%, SD 0.35 vs. 1.62%, SD 1.4; p = 0.002). Dose response studies on aplastic CD34+ cells demonstrated that at low concentrations of Epo, IL‐3 and GM‐CSF, clonogenic growth was significantly impaired but achieved normal values at concentrations giving plateau growth in control cultures. However, for all colony types, responses to effective concentrations of c‐kit ligand corresponded with those of controls. These data suggest abnormalities at the receptor or signal transduction levels.Keywords
This publication has 24 references indexed in Scilit:
- Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemiaEuropean Journal of Pediatrics, 1994
- Transmembrane Receptors and Intracellular Pathways that Control Cell ProliferationAnnual Review of Physiology, 1992
- The receptors for regulatory molecules of hematopoiesisEuropean Journal of Haematology, 1992
- MARROW STEM CELL AND STROMA CELL FUNCTION IN APLASTIC ANAEMIABritish Journal of Haematology, 1991
- Responsiveness of bone marrow erythropoietic stem cells (CFU‐E and BFU‐E) to recombinant human erythropoietin (rh‐Ep) in vitro in aplastic anemia and myelodysplastic syndromeAmerican Journal of Hematology, 1990
- Aplastic anemia associated with in vitro inhibition of erythropoiesis by bone marrow‐adherent cells*European Journal of Haematology, 1988
- Characterisation of stroma‐dependent blast colony‐forming cells in human marrowJournal of Cellular Physiology, 1987
- Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage HematopoietinScience, 1985
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978